Innospec Q4 profit rises to $47.4 million; revenue falls 2% to $455.6 million
Innospec reported fourth quarter and full year 2025 results. Fourth quarter revenue fell 2% to $455.6 million, while GAAP net income rose to $47.4 million from a prior-year loss that included a UK pension settlement charge. Full-year revenue fell 4% to $1.78 billion and adjusted EBITDA fell 10% to $203.0 million, so the year's operating trend was weaker even though GAAP earnings improved.
Key points
- Q4 GAAP net income of $47.4 million, or $1.91 per diluted share, versus a net loss of $70.4 million, or $2.80 per share, a year earlier
- Q4 adjusted non-GAAP EPS of $1.50 versus $1.41 a year ago; full-year adjusted EPS of $5.27 versus $5.92 in 2024
- Full-year adjusted EBITDA of $203.0 million, down 10% from $225.2 million; net cash of $292.5 million at December 31, 2025
The filing
Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:55 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 18, 2026.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.